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Abstract 
Introduction
Children and young people (CYP) in many high-income settings have poor healthcare outcomes, 
especially those with long-term conditions (LTCs). Emergency and outpatient hospital service use is 
increasing unsustainably. To address these problems, the Children and Young People’s Health 
Partnership (CYPHP) has developed and is evaluating an integrated model of care as part of a health 
systems strengthening programme across two boroughs of London, UK that are characterised by 
mixed ethnic populations and varying levels of deprivation. The CYPHP Evelina London model of care 
comprises proactive case-finding and triage, specialist clinics, and transformative education and 
training for professionals working with CYP. Services are delivered by multidisciplinary health teams 
with an emphasis on increased coordination across primary, community, and hospital settings and 
integration of physical and mental healthcare that accounts for the CYP’s social context.
Methods and analysis 
The phased roll-out of the CYPHP Evelina London model allows an opportunistic population-based 
evaluation using a cluster randomised controlled trial design. Seventy GP practices across two 
London boroughs, grouped into 23 clusters, were randomised to provide either the CYPHP model of 
care (n=11) or enhanced usual care (n=12).
The evaluation will measure the impact of the CYPHP Evelina London model of care on child and 
parent health and wellbeing, healthcare quality, and health service use up to two years post-
implementation. A population-level evaluation will utilise routinely collected pseudonymised 
healthcare data to conduct a service-use analysis for all CYP registered with a participating GP 
(n=~90,000) with the rate of non-elective admissions as the primary outcome. We will seek consent 
from a subset of this population, with specific conditions (target n=2138) to assess the impact on 
patient-reported outcomes using the PedsQL as the primary outcome.
Ethics and dissemination
Ethics approval obtained from South West - Cornwall & Plymouth Research Ethics Committee. 
Results will be submitted for publication in peer-reviewed journals. Findings will be generalisable to 
community-based models of care, especially in urban settings. Our process evaluation will identify 
barriers and enablers of implementation and delivery of care salient to the context and condition.
Trial registration number: Clinicaltrials.gov Identifier: NCT03461848; Pre-results.
Keywords: Child health, integrated care, cluster randomised controlled trial
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Strengths and limitations of this study
 The Children and Young People’s Health Partnership (CYPHP) Evelina London model of care is a 
new model of integrated, comprehensive, coordinated, and tailored care that will be delivered 
to a population catchment of over 90,000 children and young people across a large and diverse 
area of south London, UK. 
 The opportunistic cluster randomised controlled trial design enables unique and rigorous testing 
of a new model of care, as a population level health services intervention, for child health in the 
UK.
 Patient-reported and routine service use data will provide information on effectiveness and cost-
effectiveness of the CYPHP model of care on outcomes relating to CYP health and wellbeing, 
healthcare quality, and health services and systems. Linkage of pseudo-anonymised health 
service use data will allow population level impact on patterns of service use to be assessed.  
 It is anticipated that not all eligible CYP will participate in the intervention or evaluation; our 
population-based approach to case finding, and recruitment through a patient portal, may 
present challenges for some patients, for example with language, literacy, or technology 
barriers. These factors mean that interventions may not reach those most in need. However, we 
will assess population level factors, including equity, and through a robust process evaluation 
that aims to identify barriers and enablers to accessing the new model of care and gain detailed 
information about implementation.
Page 3 of 23
For peer review only - http://bmjopen.bmj.com/site/about/guidelines.xhtml
BMJ Open
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For peer review only
4
Introduction
Approximately 20% of childhood deaths across the USA, England, Australia, and New Zealand are 
thought to be preventable through better clinical care and patient self-management, with higher 
proportions in specific categories such as children and young people (CYP) with chronic conditions.1 
Between 60 and 70% of children who died in the UK between 2001 and 2010 had a chronic condition 
requiring frequent contact with the health system.2 
Chronic, non-communicable disease accounts for 79% of all disability adjusted life years lost (DALYS), 
in young people aged 1-14 years across Europe, with respiratory diseases (mainly asthma), 
neuropsychiatric disorders, congenital abnormalities and musculoskeletal disorders the predominant 
causes of morbidity.3 This is mirrored in data from North America and Australia.4-5 
The current model of hospital-centered paediatric care in high-income countries was developed to 
deliver acute inpatient and high intensity specialist services, rather than high quality care for CYP 
with LTCs who need multidisciplinary, coordinated planned care to prevent illness and disease 
complications, and to maximize wellbeing and developmental potential.6 The current healthcare 
model, in the context of the wider health and social care system in the UK, has resulted in 
suboptimal health outcomes for both acute and chronic illness.7-8 Finally, current services are not as 
responsive to families' needs as they should be, and are often inefficient with a reliance on high-cost 
emergency department attendance and acute admissions.3,6,9 This is mirrored by inefficiencies seen 
in other high-income countries.10 There is an urgent need to develop new evidence-based, cost-
effective and sustainable health care services to meet the increasing demands caused, in part, by the 
rising prevalence of chronic illness across the life course.3,11-13 
The CYPHP Evelina London model was conceived in response to the evolving health care needs of 
CYP, and the dearth of evidence for health service commissioners and planners on how to address 
these needs. The CYPHP Evelina London model is an innovative approach to reshaping everyday 
healthcare services, expanding on the principles of integrated care.14-15 CYPHP Evelina London brings 
together physical and mental healthcare, and delivers services taking into account the social context 
of the family. It integrates primary and secondary healthcare, and links healthcare with local 
government efforts to improve the wider determinants of health. A major focus of the CYPHP 
Evelina London model is improving front line care for all CYP. This is vital as primary care and 
accident and emergency departments are where the majority of healthcare is delivered in the UK 
context, and act as the gateway to other services. Front line care can therefore be an enabler or 
barrier for the rest of the system to function well. In particular, effective and efficient urgent care is 
important to ensure that sufficient resources are available for the planned, proactive, 
comprehensive care that CYP with LTC need. This evaluation of the CYPHP Evelina London model of 
care is designed to generate robust evidence on effectiveness and cost-effectiveness of an 
integrated model of care for CYP when delivered at scale to inform local, national, and international 
service providers and commissioners. 
Evaluation overview
The evaluation, a population-based cluster randomised controlled trial (cRCT) with over 90,000 CYP 
has four component parts: 1) a pseudonymised population-based evaluation for all CYP in 
participating GP practices, 2) an evaluation of patient-reported outcomes from CYP with one of four 
specific (or ‘tracer’) conditions, 3) a process evaluation, and 4) an economic evaluation. The broad 
evaluation aims are: 
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(i) To evaluate the impact of the Children and Young People's Health Partnership (CYPHP) Evelina 
London model of care on the health, healthcare, and health service use of CYP; at the population 
level and for CYP with tracer conditions.
(ii) To understand through the process evaluation how and why the CYPHP Evelina London model is 
effective or ineffective, and to identify contextually relevant strategies for successful 
implementation as well as practical difficulties in adoption, delivery, and maintenance to inform 
wider implementation.
(iii) To assess the costs of delivery and cost-effectiveness of the CYPHP Evelina model of care 
compared with enhanced usual care (EUC), through the economic evaluation. 
Differences in outcomes will be compared (i) between practices delivering the CYPHP model 
compared with practices delivering EUC up to two years’ post-implementation of the service and (ii) 
before implementation of the model compared with up to 2 years after. 
Methods and analysis
Study design
The implementation of the CYPHP Evelina London model of care across Lambeth and Southwark will 
occur in stages. This phased roll-out allows the application of an opportunistic cRCT, where for the 
first stage (lasting for approximately two years) GP practices are randomised to either the full CYPHP 
Evelina London model (intervention) or enhanced usual care (EUC - control). The results of this 
evaluation will inform local decision-makers about whether and/or how to roll out the CYPHP Evelina 
London model to the EUC GP practices.
Population evaluation
A population-level evaluation will use routinely collected, pseudonymised primary and secondary 
healthcare data to conduct a service-use and economic analysis for all CYP registered with a 
participating GP. The model will be evaluated at a population level by comparing health service use 
(i) between CYP from the CYPHP Evelina London model and EUC clusters, and (ii) to historical data 
within the CYPHP Evelina London model and EUC arms (i.e. before-after comparison). This before-
and-after analysis will allow us to compare the CYPHP Evelina London model to the healthcare 
offered before any enhanced care was introduced. 
Objectives of the population evaluation are:
 To compare health service use (including non-elective admissions, emergency department 
attendance, outpatient appointments, GP attendances) over time, before and after intervention 
implementation, and between the CYPHP Evelina London model and EUC practices.
 To examine the impact of socio-demographic determinants, specifically measures of deprivation, 
on health service use over time and between the CYPHP Evelina London model and EUC 
practices. 
Page 5 of 23
For peer review only - http://bmjopen.bmj.com/site/about/guidelines.xhtml
BMJ Open
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For peer review only
6
Tracer condition evaluation 
A subset of the population with specific conditions (asthma, epilepsy, constipation, eczema) will be 
invited to consent for follow-up, as part of our tracer condition evaluation, to assess the impact of 
the CYPHP Evelina London model on patient-reported outcomes. These tracer conditions were 
chosen as they are examples of long term and common conditions, which will provide generalisable 
lessons about improving outcomes through healthcare for CYP with ongoing conditions. 
Objectives of the tracer condition evaluation are:
 To assess the impact of the CYPHP Evelina London model on CYP’s health-related quality of life, 
parent-reported disease severity, prevalence and severity of mental health difficulties, and 
mental wellbeing among parents over time, before and after intervention implementation, and 
compared with EUC practices. 
 To assess the equity of service access and delivery (activity, costs, outcomes) across 
socioeconomic backgrounds
Process evaluation 
A nested process evaluation will explore how well the CYPHP Evelina London model has been 
implemented and its impact on quality of care (e.g. patient/family experience, case notes audits, 
prescribing rates). Objectives relating specifically to the process evaluation and details of methods 
are presented in our accompanying process evaluation protocol entitled ‘The Children and Young 
People’s Health Partnership Evelina London Model of Care: Process Evaluation Protocol’.
Economic evaluation
We will assess the cost to the NHS of delivering the CYPHP Evelina London model, cost savings in 
relation to any decrease in health service use, and cost effectiveness of the model in terms of utility 
in relation to health-related quality of life of CYP with tracer conditions.
 Objectives of the economic evaluation are:
 To quantify the differences in resource use and costs linked to professional contacts and services 
delivered in managing the tracer conditions between the CYPHP Evelina London model and EUC.
 To assess secondary healthcare contacts and costs to the NHS.
 To evaluate cost-effectiveness by combining evidence on cost impacts and health-related quality 
of life outcomes for CYP with tracer conditions.
Hypothesis
We hypothesise that patients from both the CYPHP Evelina London model and EUC practices will 
show improvement in health outcomes between baseline and follow-up up to two years post-
implementation. However, we hypothesise that the impact on health outcomes will be significantly 
greater in patients from CYPHP Evelina London practices compared with patients from EUC 
practices. In addition, we anticipate that savings attributed to service activity reductions at a 
population level will outweigh the costs of running the service and that the service will be cost-
effective at the tracer condition level.   
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Study setting
The study is being run in two inner-city boroughs of South London in the UK, Lambeth and 
Southwark. Child health outcomes for these two inner city boroughs are worse in many instances 
than average in England, with high and rising A&E attendance rates for CYP, emergency hospital 
admissions, and hospital outpatient use.16 The CYPHP Evelina model of care components are being 
rolled out across GP practices, schools, and hospitals within Lambeth and Southwark.
Interventions
The CYPHP Evelina London model aims to provide comprehensive coordinated care for CYP, and 
tailored care that is responsive to patients’ needs. In practice this means integrating primary and 
secondary healthcare, physical and mental healthcare, healthcare with public health, and improving 
the age appropriateness of care. Providing tailored care that is responsive to patients’ needs will be 
achieved through roll-out of several universal and targeted services, and through health system 
strengthening initiatives including intra- and inter-sectoral partnerships, workforce training, 
technology, and analytics. CYPHP intervention functions have been designed to target barriers to 
effective management of physical, mental and social determinants of health at both a service-
provider and patient-level to maximise behaviour change. Further details of the underlying theory 
and activities involved in the model of care, and the health needs it seeks to address, are described 
in our model of care paper.17 During phased roll out and the evaluation trial, the CYPHP Evelina 
London model comprises two groups: 1) interventions that are being implemented across both arms 
of the trial, called “enhanced usual care” (EUC) and 2) The full CYPHP Evelina London model, 
comprising EUC plus additional interventions. Thus, EUC serves as the control arm, and the full 
CYPHP Evelina London model serves as the intervention arm. Services include care for CYP and 
support for parents and GPs; described in detail below. 
Enhanced usual care (control arm)
All practices within Lambeth and Southwark will receive:
 Decision support tools for GPs comprising guidelines (in line with national evidence-based 
guidelines), algorithms, and referral guidance for common conditions such as constipation, 
eczema, urinary tract infection, enuresis, headache and food allergies. They are in an electronic 
format, embedded into local GP data systems so that they can be accessed easily during a 
consultation.
 Paediatric hotline enabling rapid communication between GPs and paediatricians to discuss 
urgent support, management, or referral of an individual child or young person. 
 School-based emotional resilience building and mental health first aid.
 Minor illness and wellness support and services for the most common problems and illnesses, to 
help parents and professionals to keep CYP well at home.
 CYPHP Health Checks for CYP with tracer conditions (asthma, epilepsy, eczema, constipation) 
and their parents – a biopsychosocial questionnaire which supports tailored care planning.
 CYPHP Health Packs for CYP and their parents, comprising self-management support, health 
promotion, and health education material.
Parents of patients with tracer conditions are invited to complete a condition-specific 
biopsychosocial questionnaire (CYPHP Health Check) about disease or condition status, emotional 
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wellbeing, and social factors. Invitation to complete the Health Check will happens by one of four 
methods. First, eligible families are identified by their GP and sent a letter and text messages that 
invites them to complete an online CYPHP Health Check. Second, GP practices and secondary care 
sites (e.g. specialist clinics, outpatient departments) have paper copies of the Health Check available 
with pre-paid envelopes. Third, patients may self-direct to the Health Check web page which is 
promoted widely, for example through schools, community events, pharmacists, and social media. 
Finally, healthcare providers may directly refer patients to the service. Information from the CYPHP 
Health Check will be added to patients’ GP records, and families will be sent a summary of their 
scores on the questionnaire and a CYPHP Health Pack.
CYPHP Evelina London model (intervention arm)
In addition to the components of the EUC arm, the CYPHP Evelina London model comprises two 
types of clinical services: targeted care for CYP with ongoing (tracer) conditions, and universal care 
available for CYP with any condition. 
CYP with tracer conditions are eligible for a tailored clinical service delivered by the multidisciplinary 
CYPHP Health team in primary and community care settings and in patient’s homes. CYP and families 
complete a CYPHP Health Check which provides information for triaging and tailoring care. The 
CYPHP Health Team comprises specialist children’s nurses, a children’s pharmacist, mental health 
workers, associated school nurses, and backed up by Consultant Paediatrician, Child and Adolescent 
Psychiatrist, and GP. Care includes health promotion, preventive, and reactive care, and integrates 
services both vertically across primary and secondary care and horizontally between sectors.
CYP with any condition are eligible for “in-reach” CYPHP clinics. These clinics are integrated child 
health clinics jointly run by GPs and local “Patch Paediatricians” who are linked to a cluster of GP 
practices. Clinics are held in primary care settings. They offer generalist and specialist advice co-
located and coordinated conveniently close to home for patients. In-reach clinics will typically be for 
CYP who would otherwise have been referred to hospital for an outpatient appointment with a 
general paediatrician. In-reach clinics also aim to improve clinical decision-making, provide shared 
learning opportunities, and through building trust, cooperation, and direct and virtual team-working 
between GPs and Patch Paediatricians, integrates services vertically across primary and secondary 
care.
The hypothesised active components of interventions available in each arm have been mapped 
against the 12 domains of the Theoretical Domains Framework (TDF) to evidence the proposed 
mechanism through which the intervention becomes effective (Table 1, end of manuscript). The TDF 
is a synthesis (from across existing theories) of the different behavioural domains which 
interventions may target to influence behaviour change.18 Thus, the TDF is useful for aiding 
intervention design and for process evaluations that aim to determine whether mechanisms of 
actions were as anticipated. While some services are available in both arms and are hypothesised to 
improve outcomes (e.g. education & training), we hypothesise patients receiving the CYPHP Evelina 
London model will have significantly improved outcomes than patients receiving EUC by the additive 
behavioural domains targeted and the increased intensity through which domains are targeted due 
to the mode of administration. For example, Health Packs received in EUC target ‘Motivation and 
Goals’ by novel goal setting and action planning exercises. However, while this material is delivered 
passively through written material in EUC, ‘Motivation and goals’ will be targeted in patients 
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receiving CYPHP care through goal-based outcome measures for children and nurses being able to 
talk through the material face-to-face and provide feedback on meeting those goals.
Study eligibility criteria
For the population level evaluation, using pseudonymised data, there are very broad eligibility 
criteria, as the purpose of the evaluation is to include as many CYP as possible. The only criteria are 
that the CYP is (i) <16 years of age at the time of service roll out, and (ii) registered with a 
participating practice in Lambeth and Southwark. For the tracer condition evaluation, the same 
eligibility criteria as the population evaluation apply, and in addition CYP must be diagnosed or 
identified as having one or more of the four tracer conditions (constipation, eczema, epilepsy, 
asthma), express interest in the study when completing a CYPHP Health Check (described below) and 
give informed consent (described below). 
Participants will be excluded from the evaluation if any of the following applies:
 If during the evaluation period, the patient diagnosis changes and a tracer condition no longer 
applies. 
 If the patient is no longer registered with a participating practice (Of the total 89 practices in 
Lambeth and Southwark, all are participating except 19 pilot practices).
 If the patient moves their primary residence outside of Lambeth or Southwark.
Randomisation and blinding
As part of the implementation of the CYPHP Evelina London model within Lambeth and Southwark, 
GP practices were grouped into virtual clusters. Where possible, clusters were created aligned to GP 
Federation “neighbourhoods” or other existing groupings. These primary care practice clusters 
consist of 2-4 GP practices grouped together to allow the practices to share resources and hold “in-
reach” CYPHP clinics with a local “Patch Paediatrician”.
Of the 89 GP practices within Lambeth and Southwark, 19 practices took part in pilot testing of some 
components of the CYPHP Evelina London model of care. As such these 19 practices were not 
randomised. 
Randomisation was at the level of primary care practice cluster. Seventy GP practices were grouped 
into 23 clusters and were randomised to receive either the CYPHP Evelina London model of care 
(n=12) or enhanced usual care (EUC) (n=11). Clusters were initially stratified by borough. A restricted 
randomisation was then carried out on the 23 clusters. Restriction ensured minimal difference 
between intervention and control arms with regard to: 
 Baseline Index of Multiple Deprivation (IMD) - difference in mean IMD score <2.5 (mean IMD 
30, range of IMD mean score by cluster 20-37)
 Income Deprivation affecting children index (IDACI) - difference in mean IDACI < 2.5 (mean 
IDACI 29, range 17-37)
 CYP population under-16 per GP cluster - difference in mean population < 1000 (mean 
under-16 population 3914, range 2951-5674)
 OutPatient clinic referrals - difference in mean number of referrals <100 (mean number of 
OP referral 373, range of 256-505) 
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We generated 56,580 unique randomisations which met the restriction criteria. We checked that 
cluster pairs were not always grouped together. From these 56,580 randomisations we selected one 
at random. 
The evaluation will not be blinded at the level of the service delivery or participant. Study personnel 
are blinded to allocation at the time of recruitment and assessment. Stages of identification, 
recruitment, randomisation and assessment are highlighted in Figure 1 using a cluster trial timeline 
diagram.19
Recruitment and Consent
For the population evaluation, data sharing agreements have been established for access to 
pseudonymised data for all CYP across the two boroughs. Individual-level recruitment and consent is 
not required for the population evaluation since administrative data are provided to the research 
team in pseudononymised form. The data is termed pseudonymised as it is only identifiable by a 
third party (data custodian) who has access to the “pseudonymisation key” which allows record 
linkage. 
For the tracer condition evaluation, at completion of the Health Check, parents of CYP with a tracer 
condition will be provided with written information for both the parent and CYP about the 
evaluation and invited to participate in the evaluation. The informed consent process to participate 
in the evaluation and follow-up can take place through the web-based portal, in person, or by post. 
Parents will be asked to: (i) provide informed consent for the evaluation team to access their child’s 
clinical details including Health Check information, and have access to, and link, the child’s GP and 
hospital data to assess the impact of CYPHP on both primary and secondary health service use, (ii) 
complete an evaluation questionnaire at baseline (including health related quality of life measured 
by PedsQL and CHU9D, and parental wellbeing measured by the Warwick-Edinburgh Mental 
Wellbeing Scale), and (iii) give informed consent to be contacted to participate in qualitative studies 
evaluating the service. Information sheets will make it clear that parents can consent or refuse 
consent to any of these components. Participants will be free to withdraw consent without prejudice 
at any time.  A parent/carer alone or with their child may be involved in the recruitment process. If 
the CYP is under 12 years of age the parent/carer will be asked to provide, on behalf of the child, 
informed consent, if they are happy to take part in the evaluation. If the CYP is between 12 and 16 
years of age, the parent will be asked to provide informed consent and if the CYP is available at the 
time when parental consent is requested, the CYP will be asked to provide assent if they wish to 
participate. Questionnaire data for patients with epilepsy is not eligible for the primary comparison 
between intervention and EUC practices because these patients are primarily managed under 
secondary care and are found through a different case finding procedure. As such, their experiences 
of the CYPHP Evelina model of care may be different than the other three conditions. However, their 
questionnaire data will be used for a before-after, epilepsy-specific comparison and they are still 
included in the process evaluation so that we can understand their experience of care (see Figure 2). 
To compensate parents/carers for their time in completing the questionnaires, they will be provided 
with a £5 gift voucher on completion of the baseline and final follow-up assessments. In addition, 
following completion of the second assessment, participants will be enrolled into a draw for a tablet 
computer. Details of recruitment of participants for the process evaluation are outlined in the 
accompanying paper entitled ‘The Children and Young People’s Health Partnership (CYPHP) Evelina 
London Model of Care: Process Evaluation Protocol’.
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Follow-up
Participants who consent to take part in the tracer condition evaluation will be followed for up to 
two years and will be asked to complete two questionnaires about the health of their child during 
the follow-up period. Questionnaire completion may occur up to four months after the end of the 
follow-up period.
Outcomes
Outcome measures include parent-reported child health, health service use, and economic impact. 
Process outcomes, including quality of care, are described in the accompanying process evaluation 
protocol entitled ‘The Children and Young People’s Health Partnership Evelina London Model of Care: 
Process Evaluation Protocol’. The methods to assess outcomes are both quantitative and qualitative. 
“Self”-reported outcomes collected include parent-reported and child-related, and parent-related, 
and child self-reported outcomes, where appropriate. Self-report outcomes will be completed at 
baseline and up to two years’ post-implementation of the service. For all outcomes, differences in 
outcomes will be compared betwe n practices delivering the CYPHP Evelina London model 
compared with practices delivering EUC, up to two years’ post-implementation of the service. In 
addition, the impact of the CYPHP Evelina London model will be assessed by comparing outcomes 
before implementation of the model compared with up to 2 years after.
Population evaluation outcomes
The primary outcome of the population evaluation is the difference in the rate of non-elective 
hospital admissions (count per patient-year) among CYP from practices delivering the CYPHP Evelina 
London model compared with practices delivering EUC. Secondary outcomes of the population 
evaluation will be rates of primary and secondary health service use, including GP attendances, 
emergency department attendance, outpatient appointment referrals, outpatient appointment 
attendances, ambulatory care sensitive admissions, proportion of non-elective admissions that are 
ambulatory care sensitive, and rate (sum per patient-year) of non-elective admissions and 
outpatient appointment referrals, combined. Table 2 lists the indicators of healthcare use that will 
be measured using routinely collected health services data, in pseudonymised format.
Table 2. Population evaluation outcome measures
Primary Outcome: 
 Rate of non-elective admissions
Secondary Outcomes:
GP attendances 
Emergency department attendances
Outpatient appointment referrals 
Outpatient appointment attendances
Ambulatory care sensitive admissions
Proportion of non-elective admissions that are ambulatory care sensitive
Rate (sum per patient-year) of non-elective admissions and outpatient appointment referrals
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Tracer condition evaluation outcomes
The primary outcome measure of the tracer condition evaluation is health-related quality of life 
(HRQOL), as measured by PedsQL.20 The PedsQL is a brief, standardized, generic assessment 
instrument that systematically assesses patients' and parents' perceptions of health-related quality 
of life in paediatric patients. The PedsQL is based on a modular approach to measuring HRQOL and 
consists of a 15-item core measure of global HRQOL and eight supplemental modules assessing 
specific symptom or treatment domains. The survey integrates generic core scales and disease-
specific modules.
Secondary outcomes of the tracer condition evaluation include health service use, physical condition 
symptom severity, mental health, and parental wellbeing. Health service use will be analysed using 
individual data with consent, and aggregate pseudonymised data. Consent will be requested to link 
patient-level primary and secondary healthcare use data to analyse the impact of the CYPHP Evelina 
London model on both primary and secondary health service use. In addition, pseudonymised data 
on healthcare use will be aggregated for all CYP with tracer conditions allowing analysis of the 
impact of the model on all patients in this population. A further benefit in using pseudonymised data 
is that it will help to characterise (but not identify) patients that declined to participate, or did not 
engage. This will identify distributional equity issues by examining the differential impact on costs 
and outcomes for different patient and social groupings.
Physical condition symptom severity, mental health, and parental wellbeing will be analysed using 
data derived from the CYPHP Health Check questionnaires which are used by clinicians for 
biopsychosocial assessment and tailoring care, and if consent is given data will also be used for 
evaluation (Table 3). The CYPHP Health Check includes a condition-specific disease severity 
questionnaire for each of the four tracer conditions, the Strengths and Difficulties Questionnaire 
(SDQ) to measure mental health, and a bespoke measure of social conditions (e.g. parental mental 
health, social deprivation). The Strengths and Difficulties Questionnaire (SDQ) is completed as part 
of the Health Check to provide an estimate of the prevalence and severity of mental health 
difficulties of CYP with tracer conditions, as measurement of mental health is not routinely collected 
by (physical) health services within the UK.  Scores on the SDQ is being used as part of clinical 
practice to assess child mental health symptoms and help tailor care specific to need.21 The SDQ is a 
standardised screening questionnaire used extensively in mental health research with young 
people.22 The SDQ consists of 25 questions arranged to create four subscales (measuring emotional 
symptoms, conduct, hyperactivity and inattention and peer relationship difficulties). The impact 
supplement will also be completed. A version can be completed by the parent/carer for CYP aged 2-
17. The Asthma Control test is being used to assess severity of physical symptoms in patients with 
asthma. The ACT is a self-report measure designed for adults and adolescents 12 years or older.23 
The Childhood Asthma Control Test is used for CYP aged 4 to 11 years old. The ACT has 5 items 
asking about patients’ symptoms over the past 4 weeks; which are each scored on a 5-point scale. 
The Childhood ACT has 7 items which use a 5-point scale but where 4 questions are answered by the 
child and 3 questions are answered by the parent/carer using the same 4 weeks’ reference frame. 
Patients with eczema (or their parents/carers) complete the Patient Oriented Eczema 
Measure (POEM).24 The POEM is a tool used for monitoring atopic eczema severity. It focuses on the 
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illness as experienced by the patient. The scale includes 7 items with a one-week reference frame, 
and produces a score (0 to 28) and severity level (“clear or almost clear” to “very severe eczema”). 
Patients with constipation and/or epilepsy (or their parents/carers) will be asked to complete 
bespoke condition-specific measures created for the purposes of the clinical service. Measures were 
created by CYPHP clinicians and researchers based on NICE guidelines and clinical utility.
Additional measures, for evaluation only, are asked of parents/carers who have given their consent. 
The Child Health Utility 9D (CHU 9D) is a generic measure of quality of life that can be applied to 
paediatric populations.25 The measure consists of items with preference weights that give utility 
values for each health state described, allowing the calculation of Quality Adjusted Life Years 
(QALYs) for use in cost utility analysis. The scale has 9 dimensions and each item is scored on a 5-
point scale. The Warwick-Edinburgh Mental Well-Being Scale (WEMWBS) is a 14-item scale of 
mental well-being, validated for adults. WEMWBS covers subjective well-being and psychological 
functioning, in which all items are worded positively and address aspects of positive mental health.26 
Table 3. Tracer condition outcome measures used as part of clinical service and study evaluation
Domain measured Outcome measure
Self-report measures used for clinical service and evaluation (CYPHP Health Check)
Asthma severity Asthma Control Test (ACT)
Eczema severity Patient Oriented Eczema Measure (POEM)
Bristol Stool Chart (BSC)Constipation severity
Bespoke constipation questionnaire
Epilepsy severity Bespoke epilepsy questionnaire
Mental health concerns Strengths & Difficulties Questionnaire (SDQ)
Social context Bespoke social screen questionnaire 
- Social Deprivation (3 items)
- Parent mental health (1 item)
- Employment (1 item)
- Ethnicity (1 item)
Self-report measures used for evaluation
Primary outcome: Health-related quality of life Pediatric Quality of Life Inventory (PedsQL)
Economic data on child quality of life Child Health Utility 9D (CHU-9D)
Parental wellbeing Warwick-Edinburgh Mental Wellbeing Scale
Health service use (individual level data linked with consent)
Rate of non-elective admissions
GP attendances 
Emergency department attendances
Outpatient appointment referrals 
Outpatient appointment attendances
Ambulatory care sensitive admissions
Proportion of non-elective admissions that are ambulatory care sensitive
Rate (sum per patient-year) of non-elective admissions and outpatient appointment referrals
The economic evaluation includes assessment of implementation, and primary care and hospital 
services, primarily from a National Health Service perspective. Implementation inputs will be 
measured through activity logs used to record time, equipment, and building space and costed using 
national and locally relevant unit costs. Resource use and costs of services delivered in primary care 
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will be evaluated through use of CYP contact data with specific professionals and services delivered 
within primary care settings, combined with national and locally relevant unit costs. Hospital-based 
service contacts will be identified through linkage between primary care and HES data systems. 
Appropriate national and local unit costs estimates will be applied to cost hospital service contacts. 
QALY outcomes relating to acute and nonacute impacts on CYP health and quality of life will be 
estimated from the Child Health Utility (CHU-9D) measure. 
Patient and Public Involvement (PPI)
The CYPHP Evelina London model was developed with key stakeholders including CYP, carers, front 
line practitioners and providers, and health service commissioners. Stakeholders were involved in 
the development of the theoretical framework for CYPHP, identification of research questions and 
refining the research methodology. A specific CYPHP PPI group was developed with CYP and their 
families and allowed us to consult with regard to all aspects of the evaluation design; including 
appropriateness of outcome measures, consent procedures, and self-management material that was 
developed as part of enhanced usual care.
Sample size calculation
For the population evaluation, pseudonymised data from all CYP (<16 years) within participating 
practices will be used to analyse the impact of the CYPHP Evelina London model on health service 
use. 11 clusters in each arm, and an average of 3800 CYP per cluster, provides over 87% power to 
detect a reduction of 20% in the rate of non-elective admissions, assuming a coefficient of variation 
of 0.142, and baseline rate of 56 admissions per 1000 person-years. The number of CYP per cluster is 
estimated conservatively based on the 89382 CYP (age 0-15) registered in 2015 in the GP practices in 
the 23 randomised clusters. The baseline rate of non-elective admissions and the coefficient of 
variation were estimated using counts of non-elective admissions per cluster from financial years 
2013-14 – 2015-16, and counts of CYP enrolled per cluster during 2013-2015. The coefficient of 
variation used in the sample size calculation was the mean of these three estimates. The rate of non-
elective admissions was the total rate estimated by combining data from the three financial years 
2013-2016.
For the tracer condition evaluation, we hypothesise that the intervention will have an effect on both 
infant health and parent health but we believe that the mechanisms may be theoretically different 
and we believe that parental wellbeing may be a potential mediator. Therefore, we have included 
both a child- and parent-based health outcome in our sample size calculations. With 11 clusters in 
each study arm, the study team will need to recruit a minimum of 1068 CYP with a tracer condition 
(asthma, constipation, or eczema) per arm (total 2138) (see ‘Recruitment and Consent’ for rationale 
why epilepsy not included in sample size calculation). This number of participants will give the study 
90% power to detect a mean minimum clinically important difference (MCID) of 4.5 points (standard 
deviation 16.5) in the primary outcome tool for child health-related quality of life (parental reported 
PedsQL),20 as used previously with CYP with chronic health conditions such as asthma.27 The 
intraclass correlation coefficient (ICC) is assumed to be 0.02 based on a study of quality of life in CYP 
with a related condition, hay fever.28 The between cluster coefficient of variation in cluster size is 
assumed to be 0.03 based on the harmonic mean and variance of cluster size derived from GP 
registrations. The recruitment target also accounts for a 30% loss to follow up. In total there are 23 
clusters, 12 in one arm and 11 in the other; as such the outlined sample size underestimates the 
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total power as we have assumed 11 clusters in each arm. This same sample size provides over 90% 
power to detect a mean MCID of 3 points (standard deviation 8.4) in the parental primary outcome 
tool, WEMWBS.26 Here the intraclass coefficient (ICC) is assumed to be 0.03, based on pilot data 
from the WISE trial.29 Again, this allows for 30% loss to follow up.
Data analysis and reporting
A detailed analysis plan will be finalised before receipt of study data. Findings will be reported 
according to the CONSORT guidelines for cluster randomized controlled trials.  Flow charts will show 
the numbers of clusters, the numbers of CYP recruited and followed up to each time point post 
recruitment. Balance between CYPHP Evelina London and EUC clusters will be presented for a pre-
defined set of potential confounding factors, and analyses adjusted for any major imbalances.  All 
analyses will take into account the cluster design.30 Summary values (of each outcome) will be 
presented for each cluster, and for CYPHP Evelina London and EUC groups compared using t-tests 
and chi squared tests for continuous outcomes and binary outcomes respectively.
 Random-effects regression analyses using individual-level data will be used to simultaneously adjust 
for the clustered design and any imbalances between CYPHP Evelina London and EUC arms; logistic 
regression models will be used for binary outcomes, Poisson regression for rates (e.g. admission 
rates) and linear regression for continuous outcomes (e.g. PedsQL scores). Effect sizes will be 
presented as odds ratios for binary outcomes, rate ratios for rates and as mean differences for 
continuous outcomes; 95% confidence intervals (CI) will also be given. Regression analyses will also 
be used to assess whether the impact of the intervention differs by wealth quintile.
Primary analyses will be intention-to-treat and include all data from participants regardless of their 
exposure to intervention activities. Per-protocol analyses will also be carried out to examine the 
impact of the intervention taking into account engagement with the respective clinical services of 
the universal EUC services and services specific to patients with tracer condition.
Ethics and dissemination
We plan to use the MATRICS (Method for Aggregating the Reporting of Interventions in Complex 
Studies)31 approach to bring together complex data from multiple sources to evaluate this complex 
intervention. Results will be disseminated through publication in peer-reviewed articles, through 
presentation at national and international meetings, and via websites including CYPHP programme, 
partners, funder, and sponsor. Results, including a lay summary, will be shared with participants 
through publicly accessible websites, and participants who gave consent will receive information 
about their contribution to the evaluation. Participant identifiable data will be removed from all 
publications.
Ethics approval was obtained from South West - Cornwall & Plymouth Research Ethics Committee 
and NHS Health Research Authority. Approval was granted on the 14th December 2017
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Table 1 Mapping CYPHP components to the constructs of the Theoretical Domains Framework
CYPHP model of care Enhanced usual care
Domain CYPHP care for tracer conditions CYPHP 'in-reach' clinics CYPHP Health Checks 
for tracer conditions
Support tools and services for 
health professionals
Education and training
Knowledge: an awareness of the 
existence of something
One-to-one appointments where 
patients can ask specific questions
One-to-one learning in joint 
clinics where opportunity to 
learn knowledge
Health packs describe to 
patients the causes and 
triggers of their 
condition 
Evidence-based guidelines, 
algorithms, and referral 
guidance for common 
conditions (e.g. urinary tract 
infection, headache, allergies)
Training to improve awareness of 
difficulties within CYP’s health to:
 GPs
 Personal advisors
 Teaching staff 
Skills: ability or proficiency acquired 
through practice
 Multidisciplinary working within 
health team fosters improved 
competence to tackle mental and 
social concerns of CYP 
 One-to-one visits with CYP helps 
improves self-management skills 
(e.g. use inhaler correctly)
GPs working with consultant 
to impart skills in managing 
certain conditions
Health packs designed 
to provide valuable 
skills-based techniques 
in managing condition 
rather simply provide 
information
Training for:
 GPs on how to communicate 
more effectively with CYP
 Personal advisors to better 
support CYP leaving care
 teachers on promoting 
emotional resilience in CYP
Social or professional role and identity: a 
coherent set of behaviours and displayed 
personal qualities of an individual in a 
social or work setting
Multidisciplinary culture of health 
staff team places emphasis and 
responsibility on treating social and 
mental health concerns in addition to 
focusing on physical condition 
Beliefs about capabilities: self-efficacy or 
acceptance of the truth, reality, or validity 
about an ability, talent or facility that a 
person can put to constructive use
Encouraging CYP and families to 
better self-manage the child’s 
condition
Teaching oth r GPs how they 
can better manage a child’s 
presentation of illnesses
Beliefs about consequences: acceptance 
of the truth, reality, or validity about 
outcomes of a behaviour in a given 
situation
Routine visits help encourage positive 
patterns of behaviour and deter 
negative patterns of behaviour by 
providing feedback by health team
Information about what 
will happen if CYP do not 
better manage their 
condition
Training on the lasting impact of 
not treating CYP mental and 
physical health early to GPs, 
teachers and personal advisors
Motivation and goals: Intention or 
mental representations of outcomes or 
end states that an individual wants to 
achieve
Goal based outcomes used routinely 
as part of clinical care to help 
encourage CYP to manage condition 
for a reason that is salient to them
Goal setting exercises 
help CYP realise why 
managing their 
condition is relevant
Memory attention and decision 
processes: the ability to retain 
information, focus selectively on aspects 
of the environment, and choose between 
alternatives
Clinical templates to aid nurses to 
talking through physical, mental and 
social barriers for CYP not self-
managing their condition effectively
Health pack material for 
CYP focuses on self-
monitoring techniques 
(e.g. take medication, 
plan for likely triggers)
 Clinical templates guide GPs 
on how to talk about issues 
commonly faced by teens
 Guidelines advise 
appropriate actions
Environmental context and resources: 
any circumstance of a person’s situation 
or environment that discourages or 
encourages the development of skills and 
abilities, independence, social 
competence and adaptive behaviour
CYPHP nurses are flexible to allow 
some patients home visits so that 
they can better understand the 
triggers for poor health symptoms. 
Appointments also longer to allow 
time for CYP to express their concerns
Patients can receive 
specialist advice, with their 
GP, within practices close to 
home rather than having to 
go to secondary or tertiary 
settings
Resources embedded into local 
GP data systems so that they 
can be accessed easily during a 
consultation to help GPs 
provide evidence based best 
practice
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19
Social influences: those interpersonal 
processes that can cause individuals to 
change their thoughts, feelings or 
behaviours
CYPHP clinics designed to 
encourage interaction with 
health professional peers to 
gain better understanding of 
condition
Emotion: a complex reaction pattern, 
involving experiential, behavioural and 
physiological elements, by which the 
individual attempts to deal with a 
personally significant matter or event
CYPHP health team is trained to focus 
on the emotional impact of the 
condition and treat with equal 
emphasis as the physical condition
Health pack material has 
sections focused on 
techniques to manage 
mood and emotional 
concerns
Clinical templates to guide care 
place focus on asking about 
any emotional concerns the 
CYP may be experiencing
All training is focused on the 
emotional concerns of CYP
Behavioural regulation: anything aimed 
at managing or changing objectively 
observed or measured actions
Clinical templates promote 
standardised way of documenting 
care delivered and received 
Clinical templates and 
guidelines provide framework 
to guide clinical care
Nature of the behaviours: description of 
how the behaviour is conducted
Documented procedures on how to 
manage the physical, social and 
emotional concerns of CYP
Behaviours taught through 
collaborative clinics will be 
taken by GPs to utilise in 
regular practice
Visual information on 
how to conduct positive 
self-management 
behaviours
Guidance on appropriate 
behaviours to follow in 
providing support
Training to discourage 
maladaptive behaviours and 
foster new patterns
Green = Active delivery (e.g. face-to-face, guided demonstration)
Yellow= Passive delivery (e.g. written text, leaflet)
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Figure 1. Timeline of cluster randomised control trial process 
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Figure 2. Diagram of patients, services, and levels of the evaluation 
 
 
 
Children and young people (n= ~90,000) 
registered to a general practice (n=70) in 
Lambeth & Southwark 
 
Clusters randomised 
Enhanced Usual Care (Control) 
 Decision support tools 
 Paediatric hotline 
 School based emotional resilience training 
 Minor illness and wellness support & services 
CYP with tracer conditions 
 CYPHP health Checks 
 CYPHP Health Packs 
  
CYPHP Evelina Model (Intervention) 
Enhanced Usual Care PLUS 
 ‘In-reach’ CYPHP clinics 
CYP with tracer conditions 
 CYPHP Health team support & Services 
 
Population level evaluation (n=~90,000):  
Health service use 
 
Tracer condition evaluation (patients with asthma, eczema and/or constipation) 
(n=2138):  
Patient reported outcomes 
 
Economic evaluation  
Population level (n=90,000): Health service use against resource use 
Tracer condition (n=2138): Cost-effectiveness of service using QALY outcomes  
Follow Up (6 months and 18 months) 
Process evaluation (intervention only): 
Establish how well model has been 
implemented & impact on quality of care 
GP practices (n=70) grouped into 
clusters (n=23) 
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CONSORT Guidelines
1a Identification as a randomised trial in the 
title
 ✔
1b Structured summary of trial design, 
methods, results, and conclusions (for 
specific guidance see CONSORT for abstracts)
 ✔
2a Scientific background and explanation of 
rationale
 ✔
2b Specific objectives or hypotheses  ✔
3a Description of trial design (such as parallel, 
factorial) including allocation ratio
 ✔
3b Important changes to methods after trial 
commencement (such as eligibility criteria), 
with reasons
 ✔
4a Eligibility criteria for participants  ✔
4b Settings and locations where the data 
were collected
 ✔
5 The interventions for each group with 
sufficient details to allow replication, 
including how and when they were actually 
administered
 ✔
6a Completely defined pre-specified primary 
and secondary outcome measures, including 
how and when they were assessed
 ✔
6b Any changes to trial outcomes after the 
trial commenced, with reasons
N/A
7a How sample size was determined  ✔
7b When applicable, explanation of any 
interim analyses and stopping guidelines
 ✔
8a Method used to generate the random 
allocation sequence
 ✔
8b Type of randomisation; details of any 
restriction (such as blocking and block size)
 ✔
9 Mechanism used to implement the random 
allocation sequence (such as sequentially 
numbered containers), describing any steps 
taken to conceal the sequence until 
interventions were assigned
 ✔
10 Who generated the random allocation 
sequence, who enrolled participants, and 
who assigned participants to interventions
 ✔
11a If done, who was blinded after 
assignment to interventions (for example, 
participants, care providers, those CONSORT 
2010 checklist Page 2 assessing outcomes) 
and how
 ✔
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11b If relevant, description of the similarity of 
interventions
 ✔
12a Statistical methods used to compare 
groups for primary and secondary outcomes
 ✔
12b Methods for additional analyses, such as 
subgroup analyses and adjusted analyses
 ✔
Results and Discussion Sections from CONSORT not reported as this is a protocol
 
23 Registration number and name of trial 
registry
 ✔
24 Where the full trial protocol can be 
accessed, if available
 ✔
25 Sources of funding and other support 
(such as supply of drugs), role of funders
 ✔
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